Ivabradine reduces myocardial infarction and revascularization in coronary patients with HR>70 bpm

Published: 2008-09-16 06:23:00

Updated: 2008-09-16 06:23:00

The results of the BEAUTIFUL (Morbidity-Mortality Evaluation of the Inhibitor Ivabradine in Patients with Coronary Disease and Left Ventricular Dysfunction) study, presented at the ESC 2008 and published in the Lancet, have demonstrate that ivabradine reduces myocardial infarction and revascularization in coronary patients with HR70 bpm, according to Servier Korea.

The BEAUTIFUL study is th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.